Neil H. Bander

Dr. Neil H. Bander is the former Bernard and Josephine Chaus Professor of Urologic Oncology and current Professor Emeritus of Urology at Weill Cornell Medicine. While at Weill Cornell, his group developed the first monoclonal antibodies to prostate-specific membrane antigen (PSMA) that could bind to viable PSMA-positive cells. These antibodies enabled them to define much of the biology of PSMA, successfully target prostate cancers in patients, and demonstrate the initial clinical validation of PSMA as a target. As a result of the Bander team’s pioneering efforts over the past 25+ years, PSMA has become a target of enormous interest and activity in biopharma.
Dr. Bander is a surgeon-scientist trained in urological oncology and tumor immunology, both at Memorial Sloan Kettering Cancer Center. He has authored > 200 publications, and he is an inventor on approximately 150 US- and foreign patents. He has served on, and chaired, multiple grant study sections and review panels and received several honors, including the FC Valentine Fellowship from the NY Academy of Medicine, the Society of Surgical Oncology James Ewing Research Award, awards from the German and Japanese Urology Societies, the Prostate Cancer Foundation, and the Clark Medal for Surgical Innovation from the Royal College of Surgeons (London). He has served on several industry scientific advisory boards.